Advances in neurodegenerative diseases
Dialogues C
Congreso de los Diputados In Spain, they affect 1–1.5 million people. The report describes scientific advancements in the most prevalent ones and outlines the necessary adaptations of the healthcare and care system to address the personal, social, and economic challenge.
In Spain, they affect 1–1.5 million people. The report describes scientific advancements in the most prevalent ones and outlines the necessary adaptations of the healthcare and care system to address the personal, social, and economic challenge.
This meeting was attended by the following expert staff:
Pablo Martínez-Lage Álvarez
Scientific Director of the CITAAlzheimer Foundation.
Adelina Comas Herrera
Assistant Professorial Research Fellow at the London School of Economics. Director of the Global Observatory of Long-Term Care. United Kingdom.
Luisa María Villar Guimerans
Head of the Immunology Service at Ramón y Cajal Hospital. Coordinator of the Spanish Multiple Sclerosis Network.
José Obeso
Director of the Abarca Campal Integral Neuroscience Center (CINAC), HM Hospitals. Professor at CEU San Pablo University.